A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
Keisuke OkunoShuichi WatanabeSouvick RoyMitsuro KandaMasanori TokunagaYasuhiro KoderaYusuke KinugasaAjay GoelPublished in: British journal of cancer (2023)
We successfully established a miRNA-based liquid biopsy signature that robustly predicts the risk of ER in GC patients.